Interestingly, our results demonstrated that siRNA-targeting RIG-I reverses Dac-induced innate immune response and cell apoptosis, highlighting the implication of RIG-I in epigenetic modulation of NB treatment. This evidence concerns the gene RIGI and neuroblastoma.